Nagalingeswaran Kumarasamy

Author

YR Gaitonde Centre for AIDS Research and Education

Also Known As

Alison Grant, Anita Shet, Blessing Uche, Easter Thamburaj, Freedberg, Kenneth A., Gregory M. Lucas, Heather J Ribaudo, Hoffman, Irving, Kirui, Fredrick K, Makhema, Joseph

155

Publications

10.7K

Citations

H-Index

Concepts

All Affiliations

YR Gaitonde Centre for AIDS Research and Education Chiang Mai University Johns Hopkins University Harvard University University of Zimbabwe

About

Nagalingeswaran Kumarasamy is an author at YR Gaitonde Centre for AIDS Research and Education specializing in hiv, medicine, and sexual health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	18	752
2	Public Health	9	9	406
3	Social Sciences	2	2	34
4	Clinical Immunology	2	2	26
5	Health Sciences	1	1	71

Nagalingeswaran Kumarasamy

Publications

10.1K

Citations

H-Index

Page 1

	Year	Citations
Prevention of HIV-1 Infection with Early Antiretroviral Therapy Myron S. Cohen, Ying Qing Chen, Marybeth McCauley, New England Journal of Medicine	2011	6.9K
Cost-Effectiveness of HIV Treatment as Prevention in Serodiscordant Couples Rochelle P. Walensky, Eric L. Ross, Nagalingeswaran Kumarasamy, New England Journal of Medicine	2013	136
Analysis of Genetic Linkage of HIV From Couples Enrolled in the HIV Prevention Trials Network 052 Trial Susan H. Eshleman, Sarah E. Hudelson, Andrew D. Redd, The Journal of Infectious Diseases	2011	109
Reasons for Modification of Generic Highly Active Antiretroviral Therapeutic Regimens Among Patients in Southern India Nagalingeswaran Kumarasamy, Snigdha Vallabhaneni, Anitha J. Cecelia, JAIDS Journal of Acquired Immune Deficiency Syndromes	2005	95
The safety, tolerability and effectiveness of generic antiretroviral drug regimens for HIV-infected patients in south India Nagalingeswaran Kumarasamy, Suniti Solomon, Sreekanth K. Chaguturu, AIDS	2003	86
Undisclosed Antiretroviral Drug Use in a Multinational Clinical Trial (HIV Prevention Trials Network 052) Jessica M. Fogel, Lei Wang, Teresa L. Parsons, The Journal of Infectious Diseases PharmacotherapyHuman Immunodeficiency VirusPreventive MedicineHiv/aids CounsellingClinical Epidemiology	2013	79
Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial Mina C. Hosseinipour, Gregory P. Bisson, Sachiko Miyahara, The Lancet Pulmonary TuberculosisAntiretroviral TherapyHiv/aids CounsellingTreatment And PreventionTuberculosis Prevention	2016	79
Treatment as Prevention: Characterization of Partner Infections in the HIV Prevention Trials Network 052 Trial Susan H. Eshleman, Sarah E. Hudelson, Andrew D. Redd, JAIDS Journal of Acquired Immune Deficiency Syndromes Sexual HealthAntiretroviral TherapyPreventive MedicinePartner InfectionsTreatment And Prevention	2016	75
Late Presentation into Care of HIV Disease and Its Associated Factors in Asia: Results of TAHOD Su Jin Jeong, Claire M. Italiano, Romanee Chaiwarith, AIDS Research and Human Retroviruses Sexual HealthHiv DiseaseMedicineTreatment And PreventionClinical Epidemiology	2015	74
Raltegravir in second-line antiretroviral therapy in resource-limited settings (SELECT): a randomised, phase 3, non-inferiority study Alberto M. La Rosa, Linda J Harrison, Babafemi Taiwo, The Lancet HIV Second-line Antiretroviral TherapyTreatment And PreventionAntiviral Drug DevelopmentClinical TrialsAntiviral Therapy	2016	72

Page 1